Summary of the values of maximal active force and nH before and after PKA treatment in PLV
| Maximal force (mN/mm2) | nH | |
| Fig. 1 B | ||
| Control PLV | 52.89 ± 3.24 | 4.06 ± 0.20 |
| PKA | 52.23 ± 3.70 | 4.02 ± 0.22 |
| Control PLV | 51.89 ± 3.16 | 3.98 ± 0.21 |
| PKA + PKI | 50.23 ± 3.78 | 3.97 ± 0.18 |
| Fig. 1 C | ||
| Control PLV | 52.06 ± 3.77 | 3.74 ± 0.24 |
| sTn | 47.71 ± 4.59 | 3.87 ± 0.09 |
| sTn + PKA | 46.92 ± 4.85 | 3.84 ± 0.12 |
| Maximal force (mN/mm2) | nH | |
| Fig. 1 B | ||
| Control PLV | 52.89 ± 3.24 | 4.06 ± 0.20 |
| PKA | 52.23 ± 3.70 | 4.02 ± 0.22 |
| Control PLV | 51.89 ± 3.16 | 3.98 ± 0.21 |
| PKA + PKI | 50.23 ± 3.78 | 3.97 ± 0.18 |
| Fig. 1 C | ||
| Control PLV | 52.06 ± 3.77 | 3.74 ± 0.24 |
| sTn | 47.71 ± 4.59 | 3.87 ± 0.09 |
| sTn + PKA | 46.92 ± 4.85 | 3.84 ± 0.12 |
Maximal force was obtained by activating muscle at pCa 4.5 before plotting of the force-pCa curve at each condition. No significant difference was observed in each case.